Company intelligence / Profile preview

Ikänik Farms International

Corona, California, United States

Ownership: Private
Employees: ~9
Development stage: Other

Overview

Ikänik Farms operates as a seed-to-sale cannabis company with commercial-stage pharmaceutical-grade cannabis products. The company's Colombian subsidiary, Pideka, became the first in Colombia to receive GMP-Pharma certification for both cultivation and manufacturing, enabling export of pharmaceutical-grade cannabis products to European markets and other regions.

Therapeutic areas: OncologyNeurologyPsychiatryGastroenterology
Modalities: Cannabis-derived products (oils, extracts, cosmetics)Cannabinoid solutions
Industry: Biotech

Partnerships

CAS Biotechnology (for COVID-19 research collaboration)SGS (certification provider)

Beyond the preview

Go deeper on Ikänik Farms International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ikänik Farms International.

Explore the full profile